US 7759320
Compositions and methods for inhibiting expression of a gene from the Ebola
granted A61PA61P11/00A61P31/00
Quick answer
US patent 7759320 (Compositions and methods for inhibiting expression of a gene from the Ebola) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P11/00, A61P31/00, A61P31/14, A61P7/00